ReviewNeuropsychiatric disease and treatment2017
Assessment and monitoring of treatment response in adult ADHD patients: current perspectives.
Review in Neuropsychiatric disease and treatment, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 44 citations in OpenAlex.
- Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial.BMC psychiatry · 2022Trial
- A Study on the Validity and Reliability of the Turkish Translation of the Self-Report Wender-Reimherr Adult Attention Deficit Disorder Scale.International journal of methods in psychiatric research · 2026Article
- Validity and Reliability of the Turkish version of theWender-Reimherr Adult Attention Deficit Disorder Scale.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2026Article
- Distracted, hyperactive, and thriving: factors supporting everyday functioning in adults with ADHD.BMC psychiatry · 2025Article
- Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD - are we there yet?Journal of child psychology and psychiatry, and allied disciplines · 2025Article
- Age-related cognitive complaints and emotional difficulties associated with symptoms of ADHD: a study of gender differences.Frontiers in global women's health · 2025Article
- Evaluation of the Content Validity of the COVID-19 Symptoms Daily Diary.Patient related outcome measures · 2025Article
- Attention-deficit/hyperactivity disorder.Nature reviews. Disease primers · 2024Review
- Attention-deficit hyperactivity disorder in people with intellectual disability: statistical approach to developing a bespoke screening tool.BJPsych open · 2021Article
- ADHD and Neurodegenerative Disease Risk: A Critical Examination of the Evidence.Frontiers in aging neuroscience · 2021Review
- Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients.Rambam Maimonides medical journal · 2020Article
- Integrated Analysis of microRNA and mRNA Expression Profiles: An Attempt to Disentangle the Complex Interaction Network in Attention Deficit Hyperactivity Disorder.Brain sciences · 2019Article
- Subclinical Scores in Self-Report Based Screening Tools for Attention Deficits Correlate With Cognitive Traits in Typical Evening-Type Adults Tested in the Morning.Frontiers in psychology · 2019Article
- Co-Morbid Obsessive-Compulsive Disorder and Attention Deficit Hyperactivity Disorder: Neurobiological Commonalities and Treatment Implications.Frontiers in psychiatry · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental syndrome that emerges in childhood or early adolescence and persists into adulthood for a majority of individuals. There are many other adults with ADHD who may not seek out evaluation and treatment until adulthood, having been able to "get by" before struggling with inattention, hyperactivity, and/or impulsivity in adulthood, in addition to facing the associated features of disorganization, poor time management, and procrastination among many others. A lifetime diagnosis of ADHD is associated with a wide range of life impairments, which makes a comprehensive and accurate diagnostic assessment essential in order to obtain appropriate treatment. Moreover, while there are effective medical and psychosocial treatments for ADHD, it is important to be able to track treatment response in order to evaluate whether adjustments in specific interventions are needed or referrals for adjunctive treatments and supports are indicated to facilitate optimal therapeutic outcomes. The goal of this article is to provide a clinically useful review of the various measures that practicing clinicians can use to aid in the diagnostic assessment and monitoring of psychosocial and medical treatment of ADHD in adult patients. This review includes various structured interviews, screening scales, adult ADHD symptom inventories, measures of associated features of ADHD, as well as ratings of impairment and functioning which can be adapted to clinicians' practice needs in order to track treatment progress and optimize treatments for adults with ADHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.